六君子汤加黄芪增强肝癌化疗栓塞术后患者细胞免疫功能和疗效观察

目的：为探讨补肾防喘片，必可酮防治季节性哮喘发作的效果。方法：选择了５７例轻、中度患者并随机分为两组、治疗组３２例服补肾防喘片及吸入必可酮；对照组２５例吸入必可酮。治疗个月后复查并连续观察０．５年，治疗前后分别测定嗜酸细胞计数、可溶性白介素－２受体（ＳＩＬ－２Ｒ），嗜酸细胞阳离子蛋白（ＥＣＰ）及做肺功能、气道反应性。结果：治疗组疗效明显优于对照组。治疗组ＥＣＰ下降及１秒钟用力呼气量的增加也较对照组

Prevention and Treatment of Seasonal Asthmatic Patients by Combined Invigorating Kidney for Preventing Asthma Tablets and Beclomethasone Dipropinate

OBJECTIVE: To evaluate the efficacy of combined Invigorating Kidney for Preventing Asthma (IKPA) tablets and beclomethasone dipropinate (BDP). METHODS: Fifty seven seasonal asthmatic patients were studied. They were randomly assigned to either of the two groups: the treated group (n = 32) treated with the IKPA tablets and inhalated BDP, the control group (n = 25) inhalated BDP singly. Measurements of serum eosinophil cationic protein (ECP), soluble IL-2 receptor (SIL-2), total eosinophil counts, spirometry and methacholine challenge were performed before and after treatment. RESULTS: After 3 months' treatment and 6 months' observation the authors observed a significant improvement in both groups. The treated group had better clinical efficacy and the ECP level had reduced significantly, FEV1 increased greatly than the control group. CONCLUSIONS: The two drugs influenced the function of eosinophils and and T lymphocytes and this might contribute to the efficacy.